Bruce & Co. Inc. lowered its stake in Fate Therapeutics, Inc. (NASDAQ:FATE – Free Report) by 28.5% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 143,000 shares of the biopharmaceutical company’s stock after selling 57,000 shares during the period. Bruce & […]
Bruce & Co. Inc. trimmed its stake in shares of Fate Therapeutics, Inc. (NASDAQ:FATE – Free Report) by 28.5% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 143,000 shares of the biopharmaceutical company’s stock after selling 57,000 shares during the quarter. Bruce & […]
Brokerages Set Fate Therapeutics, Inc (NASDAQ:FATE) Price Target at $6 58 tickerreport.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tickerreport.com Daily Mail and Mail on Sunday newspapers.
Fate Therapeutics, Inc. (NASDAQ:FATE – Get Free Report) saw a large growth in short interest in the month of April. As of April 30th, there was short interest totalling 22,140,000 shares, a growth of 17.0% from the April 15th total of 18,920,000 shares. Based on an average daily volume of 2,620,000 shares, the days-to-cover ratio […]
StockNews com Lowers Fate Therapeutics (NASDAQ:FATE) to Sell dailypolitical.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailypolitical.com Daily Mail and Mail on Sunday newspapers.